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Background:  Familial screening of patients with dilated cardiomyopathy (DCM) allows an early diagnosis of the disease in family members. It is 
unclear if familial forms of DCM (FDC) have a different long-term outcome with respect to the sporadic DCM. The aim of this study was to compare 
long-term prognosis of FDC with respect to sporadic forms in order to assess the role of familial screening.
Methods:  From 1988 to 2007 we enrolled 637 consecutive DCM patients in the Trieste Heart Muscle Disease Registry. We compared non-proband 
FDC patients (NP-FDC) with a sample of 96 sporadic forms, randomly matched by year of enrolment (2:1) in order to increase the efficiency of 
comparisons.
Results:  FDC were 130 (20.4%), 82 (12.9%) were probands. The familial screening effectively diagnosed DCM in 48 (7.5%) NP-FDC patients. With 
respect to the random sample, NP-FDC patients at enrollment were younger (40±16 vs 47±13 years, p=0.002), less severely symptomatic (NYHA 
class III-IV 8% vs 28%, p=0.006), had higher left ventricular ejection fraction (35±10 vs 30±9%, p=0.005). The survival free from heart transplant 
at 2, 5 and 10 years was respectively 93, 91 and 82% in NP-FDC patients versus 86, 76 and 62% of sporadic forms (p=0.04). After stratification for 
NYHA classes, no difference in survival has been observed between sporadic and NP-FDC patients.
Conclusions:  FDC represented 20% of our population. Familial screening of DCM patients allowed early recognition of 7.5% of patients. NP-FDC 
patients which had less advanced disease at presentation and a better long-term outcome.
